Croissance Ltd (531909)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 6/9 hints at some improving financial health.
• Reported profit growth of 107.41% suggests possible positive momentum, though from a very low base.
• Positive book value of ₹1.27 per share provides a tangible asset base.
• ROCE is positive at 0.13%, so capital employed is not deeply loss-making on an operating basis.

Concerns

• Negative ROE of -3.00% indicates shareholder equity is not generating returns.
• Latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, leaving no visible earnings engine.
• P/B of 3.12 means paying a large premium to book value for a business with near-zero returns.
• P/E of 51.34 with zero dividend offers a negligible earnings yield and no income support.
• Promoter holding and debt/equity are not disclosed, creating a transparency gap.

AI Analysis

At ₹3.96, Croissance Ltd asks me to pay ₹28 crore for a company whose book value is only ₹1.27 per share. That's 3.12 times book. What do I get for that premium? A negative return on equity of -3.00%, a ROCE of just 0.13%, zero dividend, and a latest quarter with no sales and no net profit. The reported profit growth of 107.41% sounds exciting, but in Graham's language, a percentage change from a near-zero base is meaningless. A P/E of 51.34 and a PEG of 0.48 do not become attractive when the denominator is thin air. A zero revenue quarter is not necessarily fatal for a real-estate/project-based company—if it is between project completion and recognition—but it also gives me nothing concrete to value. I cannot even see promoter holding or debt details. The Piotroski score of 6/9 is the only constructive signal; it hints at some balance-sheet or operational improvement. But a 6/9 score does not create a moat. There is no pricing power, no visible competitive advantage, and no evidence of a durable earnings stream. In true value investing, I require a margin of safety: buy at a discount to intrinsic value, with conservative assumptions. Here, the market price is already well above book, while returns on capital are near zero or negative. The business appears to be in a possible turnaround, and a 107% profit growth from a small base can be the first sign of one. But I am not paid to hope. I need years of demonstrated earning power, a clean balance sheet, and management's skin in the game. Until Croissance shows real revenue, positive and consistent ROE, and meaningful profits rather than round-zero numbers, it belongs in the 'too hard pile.' In India's listed micro-cap space, a cheap-looking chart can be the most expensive illusion. I'll keep watching, but I won't buy.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer